Stockreport

Mural Oncology to Host First Virtual Investor Day on September 26, 2024

Mural Oncology plc - Ordinary Shares  (MURA) 
PDF Company will provide clinical overview and update on late-stage clinical candidate, nemvaleukin alfa, and overview of IL-18 pipeline program Clinicians to share expert [Read more]